Novel association between TGFA, TGFB1, IRF1, PTGS2 and IKBKB single-nucleotide polymorphisms and occurrence, severity and treatment response of major depressive disorder

PeerJ
Katarzyna BialekTomasz Sliwinski

Abstract

Activation of the immune system might affect the severity of depressive episodes as well as response to the antidepressant treatment. The purpose of this study was to investigate whether the occurrence of variant alleles of analyzed SNPs are involved in prevalence and progression of depression. Moreover, selected genes and SNPs have not been investigated in context of the disease severity and treatment. Therefore, six polymorphisms were selected: g.41354391A>G-TGFB1 (rs1800469), g.132484229C>A-IRF (rs2070729), g.186643058A>G-PTGS2 (rs5275), g.186640617C>T-PTGS2 (rs4648308), g.70677994G>A-TGFA (rs2166975) and g.42140549G>T-IKBKB (rs5029748). A total of 360 (180 patients and 180 controls) DNA samples were genotyped using TaqMan probes. We observed that A/G of the rs2166975 TGFA, A/C of rs2070729 IRF1 and G/T of rs5029748 IKBKB were associated with an increased risk of depression development while the T/T of rs5029748 IKBKB, T/T of rs4648308 PTGS2 and G/G of rs2166975 TGFA reduced this risk. We also stratified the study group according to gender and found that genotype A/G and allele G of the rs2166975 TGFA, G/T of rs5029748 IKBKB as well as C allele of rs4648308 PTGS2, homozygote A/A and allele A of rs5275 PTGS2 were associated w...Continue Reading

References

Jun 3, 2000·Annual Review of Immunology·M Karin, Y Ben-Neriah
Mar 27, 2001·Annual Review of Pharmacology and Toxicology·R M BreyerM D Breyer
Jun 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·S YamagiwaD A Horwitz
Feb 16, 2002·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Andrea KrögerPeter P Mueller
Nov 13, 2002·Arthritis and Rheumatism·Eugene Y KissinRobert Lafyatis
Dec 11, 2002·The European Journal of Neuroscience·Tânia Cristina Leite de Sampaio e SpohrFlávia Carvalho Alcantara Gomes
Feb 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Angelika BierhausPeter P Nawroth
May 30, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S KunzmannC B Schmidt-Weber
Apr 14, 2004·The European Journal of Neuroscience·Vivian de Oliveira SousaFlávia Carvalho Alcantara Gomes
Apr 16, 2004·Cerebral Cortex·Julie A Siegenthaler, Michael W Miller
May 8, 2004·Trends in Biochemical Sciences·Peter ten Dijke, Caroline S Hill
Jun 3, 2004·Life Sciences·Fugen Aktan
Sep 30, 2004·Journal of Neuropathology and Experimental Neurology·Luisa Minghetti
Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Olga J G SchiepersMichael Maes
Sep 27, 2005·Archives of Biochemistry and Biophysics·Markus HanssonWilliam M Nauseef
Oct 6, 2005·Human Molecular Genetics·Peter McGuffinAnne E Farmer
Nov 8, 2005·Cytokine & Growth Factor Reviews·Denis Vivien, Carine Ali
Sep 2, 2006·The American Journal of Psychiatry·Thaddeus W W PaceChristine M Heim
Feb 3, 2007·Journal of Applied Genetics·Ausra MorkūnienéVaidutis Kucinskas
Apr 17, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yong-Ku KimJung-Bum Kim
Oct 9, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Yong-Ku KimBun-Hee Lee
Feb 29, 2008·Annual Review of Immunology·Tomohiko TamuraTadatsugu Taniguchi
Mar 5, 2008·Clinical & Developmental Immunology·Levent SutcigilAli Sengul
Mar 15, 2008·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Giuliana FortunatoLucia Sacchetti
Apr 25, 2008·Current Protocols in Immunology·Kiyoshi Takeda, Shizuo Akira
Sep 26, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Zhihua Feng, Chien-Ping Ko
Oct 15, 2008·International Reviews of Immunology·Teresa Krakauer
Sep 24, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Cielito C Reyes-GibbySanjay Shete
Jan 20, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sara T PassosChristopher A Hunter
May 21, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ju ShiKatrin Andreasson
Jul 1, 2010·Neuropsychobiology·Piotr GałeckiJanusz Szemraj
Feb 22, 2011·Pharmacology & Therapeutics·Lucile Capuron, Andrew H Miller
Sep 20, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Filippo CaraciRaffaele Ferri
Dec 17, 2011·PloS One·Jairam R LingappaUNKNOWN Partners in Prevention HSV/HIV Transmission Study Team
Apr 11, 2012·Neuroscience Letters·Julien MendlewiczAlessandro Serretti
Jul 12, 2012·Journal of Neural Transmission·Wei-wei ChangYing-shui Yao
Mar 19, 2013·Annual Review of Biophysics·Johanna Napetschnig, Hao Wu
Jul 16, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Cielito C Reyes-GibbySanjay Shete
Sep 24, 2013·Molecular Psychiatry·P F Sullivan

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
Genotyping
Assay
PCR
glycosylation

Software Mentioned

Statistica
CFX Manager
SigmaPlot
displaystyle

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.